Journal of Neurology

, 254:1306 | Cite as

Mary Broadfoot Walker (1888–1974)



  1. 1.
    Keesey JC (1998) Contemporary Opinions about Mary Walker. A shy pioneer of therapeutic neurology. Neurology 51:1433–1439PubMedGoogle Scholar
  2. 2.
    Johnston JD (2005) The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London. J Hist Neurosci 14(2):121–137CrossRefPubMedGoogle Scholar
  3. 3.
    Walker MB (1934) Treatment of myasthenia gravis with physostigmine. Lancet (i):1200–1201Google Scholar
  4. 4.
    Walker MB (MRCP) (1935) Case showing the effect of Prostigmin on myasthenia gravis. Proc Roy Soc Med 28(I):759–761PubMedGoogle Scholar
  5. 5.
    Walker MB (MD) (1938) Myasthenia gravis: a case in which fatigue of the forearm muscles could induce paralysis of extra-ocular muscles. Proc Roy Soc Med 31(II):722PubMedGoogle Scholar
  6. 6.
    Walker MB (1973) Some discoveries on myasthenia gravis: the background. Br Med J 1973(2):42–43CrossRefGoogle Scholar
  7. 7.
    Walker MB (1935) A contribution to the study of myasthenia gravis. MD thesis. Edinburgh UniversityGoogle Scholar
  8. 8.
    Aitken RS, Allott EN, Castleden LIM, Walker M (1937) Observations on a case of familial periodic paralysis. Clin Sci 3:47–57Google Scholar
  9. 9.
    KSM (1974) Mary Broadfoot Walker MD Edin., MRCP. Lancet (ii):1401–1402Google Scholar
  10. 10.
    PWR (1974) Dr. Mary Walker. Lancet (ii):1582Google Scholar

Copyright information

© Steinkopff-Verlag 2007

Authors and Affiliations

  1. 1.Medicines and Healthcare productsRegulatory Agency, Floor 11, Market TowersLondonUK

Personalised recommendations